Company

Freenome

Rocket Ship Rating

Rocket Ship Rating: 97 out of 100

Outpacing cancer starts with early detection

Also known as Freenome, LLC

Biotech & therapeutics
Medical devices & diagnostics
AI native
Deeptech

Business model: B2B
Founded: 2014
Legal name: Freenome, LLC

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Next-generation blood tests for early cancer detection powered by a multiomics platform

Funding snapshot

Total raised: $800KSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $243M2021-11-22

Funding rounds

Round, 2021: $243M2021-11-22, SEC form D sold, 58 investors
Round, 2020: $270M2020-08-14, SEC form D sold, 55 investors
Round, 2019: $160M2019-06-24, SEC form D sold, 47 investors
Round, 2017: $72M2017-02-23, SEC form D sold, 24 investors
Round, 2016: $5.6M2016-05-23, SEC form D sold, 13 investors
Round, 2015: $800K2015-10-16, SEC form D sold, 4 investors

Products

Other: SimpleScreen CRC
Web: SimpleScreen CRC